Sections of the U.S. equities market (most stocks) have performed well, offering ongoing enticing opportunities despite the AI scare. Read more here.

The February 2026 plenary session saw two key votes: on the Ukraine Support Loan, reaffirming the EU's continued financial support for Ukraine; and on the EU-Mercosur agreement safeguard clause, ...

Find out how the EU is supporting Ukraine's energy security, as well as the country's infrastructure, connectivity and transport sectors.

An EU court adviser says the EU Commission wrongly released billions of euros to Hungary, and that the bloc’s top court ...

The continued use of "forever chemicals" could cost Europe up to 1.7 trillion euros ($2 trillion) by 2050 because of their impact on people's health and the environment, an EU-commissioned report said ...

The European Union has allocated 10 million euros for a special tribunal to prosecute the crime of aggression against Ukraine, according to European Union Foreign Affairs chief Kaja Kallas. Why ...

Ukrainian soldiers fire a French-made CAESAR self-propelled howitzer toward Russian positions, in the Donetsk region, on June 27, 2024, amid the Russian invasion of Ukraine. (Roman Pilipey/AFP via ...

The European Commission has formally unveiled a 90-billion-euro ($105 million) loan for Ukraine, intended to cover a large part of Kyiv’s financing needs for the next two years. The move comes on ...

The funds will be channeled through the European Bank for Reconstruction and Development and the Energy Community, an organization of nine EU candidate countries that ensure the implementation of EU ...

The crowing by British Prime Minister Keir Starmer at the agreement signed Tuesday with France to send British and French soldiers to Ukraine after a ceasefire with Russia has rapidly subsided. For ...

Jan 8 (Reuters) - Alveus Therapeutics said on Thursday it has raised $159.8 million in funding to develop obesity treatments focused on helping patients keep weight off long-term, a problem the ...

Financing supports Phase 2 development of ALV-100, IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist, ...